Literature DB >> 31887276

Predicting Severe Postoperative Complication in Patients With Lung Cancer and Interstitial Pneumonia.

Manato Ohsawa1, Yasuhiro Tsutani1, Makoto Fujiwara1, Takahiro Mimae1, Yoshihiro Miyata1, Morihito Okada2.   

Abstract

BACKGROUND: Interstitial pneumonia is linked to lung cancer, and treatment can cause acute exacerbation. We aimed to identify predictors of severe postoperative complications in patients with lung cancer and interstitial pneumonia.
METHODS: Between April 2007 and April 2017, 199 patients were diagnosed with primary lung cancer and interstitial pneumonia using high-resolution computed tomography. Multivariable logistic regression analyses were performed to identify independent predictors of severe complications (Clavien-Dindo grade IIIa or higher).
RESULTS: Multivariable analyses revealed that severe complications were independently predicted by the percent diffusing capacity of the lungs for carbon monoxide (%Dlco [odds ratio 0.88; 95% confidence interval, 0.82 to 0.95; P < .001]) and surgical procedures (lobectomy, odds ratio 4.49; 95% confidence interval, 1.86 to 23.32; P = .045). Severe complications occurred in 39.2% of patients with low %Dlco (less than 40%) and in 4.2% of patients with high %Dlco (greater than 40%). The rates of severe complications were 11.5% for patients who underwent lobectomy and 9.7% for patients who underwent sublobar resection. For patients with low %Dlco, the rates of severe complications were 85.7% for those undergoing lobectomy and 23.8% for those undergoing sublobar resection (P = .009). Overall survival (OS) was significantly different between patients with low %Dlco (5-year OS 33.5%) and patients with high %Dlco (5-year OS 65.3%; P = .001). Among patients with low %Dlco, there was a significant difference in OS between patients who underwent lobectomy (5-year OS 0%) and those who underwent sublobar resection (5-year OS 49.6%; P = .029).
CONCLUSIONS: Severe postoperative complications were predicted by %Dlco and surgery type. Sublobar resection might be a better option for patients with low %Dlco values (less than 40%).
Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31887276     DOI: 10.1016/j.athoracsur.2019.11.012

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Predictive model of postoperative pneumonia after neoadjuvant immunochemotherapy for esophageal cancer.

Authors:  Wei Wang; Yongkui Yu; Haibo Sun; Zongfei Wang; Yan Zheng; Guanghui Liang; Peinan Chen; Jiwei Cheng; Xiaoxia Xu; Funa Yang; Qi Liu; Weiqun Xing
Journal:  J Gastrointest Oncol       Date:  2022-04

2.  The surgical management of early-stage lung adenocarcinoma: is wedge resection effective?

Authors:  Ying Ji; Guangyu Bai; Bin Qiu; Liang Zhao; Jing Zhou; Qi Xue; Shugeng Gao
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

3.  Treatment of a Pulmonary Aspergilloma in a Lung Transplant Recipient Using Catheter-directed Intracavitary Instillation of Liposomal Amphotericin B.

Authors:  Andrew M Courtwright; Sarah Longworth; Donna Chojnowski; Ingi Lee; Stephen Hunt
Journal:  Transplant Direct       Date:  2021-12-23

4.  Ventilation in patients with stage IIIB or above lung cancer.

Authors:  Haiqin Zhang; Jinhua Ni; Qijian Cheng
Journal:  Ann Transl Med       Date:  2021-11

5.  Interstitial pneumonia and advanced age negatively influence postoperative pulmonary function.

Authors:  Takahiro Mimae; Yoshihiro Miyata; Takashi Kumada; Yoshinori Handa; Yasuhiro Tsutani; Morihito Okada
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-05-02

6.  Prediction of postoperative cardiopulmonary complications after lung resection in a Chinese population: A machine learning-based study.

Authors:  Guanghua Huang; Lei Liu; Luyi Wang; Shanqing Li
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.